DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
- Posted
- May 21, 2026
- Closed
- October 15, 2026
- Program funding
- $18,600,000
- Expected awards
- 6
- Cost sharing
- No
- Instrument
- Grant
- Assistance listing
- 12.420
- Archives
- November 14, 2026
Program funding history
Awards made under Assistance Listing 12.420 across FY2025–FY2027, from public federal spending records.
- FY2025 obligated
- $1.3B
- FY2026 obligated
- $598.5M
- FY2027 (to date) obligated
- $0
- Awards in window
- 4,414
Top recipients: The Univeristy of Texas M.d. Anderson Cancer Center, Regents of the University of California, San Francisco, the, University of California, Los Angeles, Icahn School of Medicine at Mount Sinai, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Source: USAspending.gov · refreshed October 2026 · Program page: awards, recipients and the opportunities under this listing →
Synopsis
Summary: The fiscal year 2026 (FY26) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Clinical Trial Award (CTA) intends to support clinical trials with the potential to have a significant impact on psychological health conditions and/or traumatic brain injury (TBI) through clinical applications, including health care products, technologies and/or practice guidelines.
Distinctive Features: Funding from this award mechanism must support a clinical trial.
· Clinical trials may be designed to evaluate a wide range of interventions, including new drugs, biologics, medical devices, diagnostics, therapies and behavioral health strategies.
· Preliminary data are required.
· The inclusion of community-based participatory research (CBPR) approaches is required.
· The CTA offers funding for two Research Levels. The applicant is responsible for selecting the Research Level based on the scope of the research.
○ Research Level 1: Supports proof-of-principle pilot studies, as well as phase 1 and phase 2 clinical trials.
○ Research Level 2: Supports larger-scale and advanced clinical trials that evaluate effectiveness in relevant patient populations.
· Early-Career Investigator Partnering Option (available for both Research Levels): This option accommodates two Principal Investigators (PIs), one of which is an Early-Career Investigator. If recommended for funding, each PI will receive a separate award.
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
The official record
Grants.gov published the official terms and dates of this opportunity; this page keeps them as they were listed.
New to federal funding? How to read an announcement · Who can apply · How grants work
Tell me when this program posts again
This round has closed. One email the morning after this program is posted again under a new number (we watch for about two years), and one more about a week before that round closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.
Similar grants
- DoW Spinal Cord Injury, Clinical Trial Award
- DoW Autism Clinical Trial Award
- DoW Vision, Clinical Trial Award
- DoW Spinal Cord Injury, Clinical Translation Research Award
- DoW Toxic Exposures Clinical Trial Award
- DoW Arthritis Clinical Research Award
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.
Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.
See pricing